134 related articles for article (PubMed ID: 29046905)
21. Decreased mRNA expression of transcription factor forkhead box F2 is an indicator of poor prognosis in patients with resected esophageal squamous cell carcinoma.
Zheng YZ; Wen J; Cao X; Yang H; Luo KJ; Liu QW; Huang QY; Chen JY; Fu JH
Mol Clin Oncol; 2015 May; 3(3):713-719. PubMed ID: 26137292
[TBL] [Abstract][Full Text] [Related]
22. Forkhead transcription factor FoxF2 is expressed in mesodermal tissues involved in epithelio-mesenchymal interactions.
Aitola M; Carlsson P; Mahlapuu M; Enerbäck S; Pelto-Huikko M
Dev Dyn; 2000 May; 218(1):136-49. PubMed ID: 10822266
[TBL] [Abstract][Full Text] [Related]
23. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers.
Kundu ST; Byers LA; Peng DH; Roybal JD; Diao L; Wang J; Tong P; Creighton CJ; Gibbons DL
Oncogene; 2016 Jan; 35(2):173-86. PubMed ID: 25798833
[TBL] [Abstract][Full Text] [Related]
24. MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2.
Zhang T; Wan JG; Liu JB; Deng M
Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829888
[TBL] [Abstract][Full Text] [Related]
25. Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production.
Ormestad M; Astorga J; Landgren H; Wang T; Johansson BR; Miura N; Carlsson P
Development; 2006 Mar; 133(5):833-43. PubMed ID: 16439479
[TBL] [Abstract][Full Text] [Related]
26. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition.
Dou C; Jin X; Sun L; Zhang B; Han M; Li T
Cancer Biomark; 2017 Jul; 19(4):447-454. PubMed ID: 28582850
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between epithelial-mesenchymal transition and basal cell-like phenotype in breast cancer].
Wu WX; Zhang YP; Wen XW; Lu N; Tang ZY; Zhang Y; Wang Z; Wang W; Yang HJ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):519-23. PubMed ID: 20021961
[TBL] [Abstract][Full Text] [Related]
28. Differences in the embryonic expression patterns of mouse Foxf1 and -2 match their distinct mutant phenotypes.
Ormestad M; Astorga J; Carlsson P
Dev Dyn; 2004 Feb; 229(2):328-33. PubMed ID: 14745957
[TBL] [Abstract][Full Text] [Related]
29. FOXF2 is required for cochlear development in humans and mice.
Bademci G; Abad C; Incesulu A; Elian F; Reyahi A; Diaz-Horta O; Cengiz FB; Sineni CJ; Seyhan S; Atli EI; Basmak H; Demir S; Nik AM; Footz T; Guo S; Duman D; Fitoz S; Gurkan H; Blanton SH; Walter MA; Carlsson P; Walz K; Tekin M
Hum Mol Genet; 2019 Apr; 28(8):1286-1297. PubMed ID: 30561639
[TBL] [Abstract][Full Text] [Related]
30. The FOXF2 pathway in the human prostate stroma.
van der Heul-Nieuwenhuijsen L; Dits N; Van Ijcken W; de Lange D; Jenster G
Prostate; 2009 Oct; 69(14):1538-47. PubMed ID: 19562724
[TBL] [Abstract][Full Text] [Related]
31. FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
Chen X; Hu H; Liu J; Yang Y; Liu G; Ying X; Chen Y; Li B; Ye C; Wu D; Duan S
Tumour Biol; 2017 Feb; 39(2):1010428317692230. PubMed ID: 28222662
[TBL] [Abstract][Full Text] [Related]
32.
Xu J; Liu H; Lan Y; Jiang R
Front Cell Dev Biol; 2021; 9():665109. PubMed ID: 33898467
[TBL] [Abstract][Full Text] [Related]
33. MiR-182 promotes cell proliferation, migration and invasion by targeting FoxF2 in endometrial carcinoma cells.
Yao H; Kong F; Zhou Y
Int J Clin Exp Pathol; 2019; 12(4):1248-1259. PubMed ID: 31933939
[TBL] [Abstract][Full Text] [Related]
34. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
35. Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients.
Shi Z; Liu J; Yu X; Huang J; Shen S; Zhang Y; Han R; Ge N; Yang Y
Ann Surg Oncol; 2016 Jan; 23(1):211-7. PubMed ID: 25824262
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-182 targets FOXF2 to promote the development of triple-negative breast cancer.
Yu J; Shen W; Gao B; Zhao H; Xu J; Gong B
Neoplasma; 2017; 64(2):209-215. PubMed ID: 28043147
[TBL] [Abstract][Full Text] [Related]
37. Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling.
Nilsson G; Kannius-Janson M
BMC Cancer; 2016 Feb; 16():142. PubMed ID: 26908052
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.
Pomp V; Leo C; Mauracher A; Korol D; Guo W; Varga Z
Breast Cancer Res Treat; 2015 Nov; 154(1):45-55. PubMed ID: 26467042
[TBL] [Abstract][Full Text] [Related]
39. Forkhead transcription factor Foxf2 (LUN)-deficient mice exhibit abnormal development of secondary palate.
Wang T; Tamakoshi T; Uezato T; Shu F; Kanzaki-Kato N; Fu Y; Koseki H; Yoshida N; Sugiyama T; Miura N
Dev Biol; 2003 Jul; 259(1):83-94. PubMed ID: 12812790
[TBL] [Abstract][Full Text] [Related]
40. Human FOX gene family (Review).
Katoh M; Katoh M
Int J Oncol; 2004 Nov; 25(5):1495-500. PubMed ID: 15492844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
